Zydus Cadila gets USFDA nod for migraine drug
Most Popular (6 hours)

PHE employees project demands

- news.statetimes.in

Most Popular (24 hours)

Blood donation camp held

- news.statetimes.in

Most Popular (a week)

business-standard
6 months ago

Zydus Cadila gets USFDA nod for migraine drug

Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.

Read on the original site


Power shutdown

- news.statetimes.in

The Strategist Quiz (#542)

- business-standard

Readers Corner: Life Insurance

- business-standard

Starry brand appeal

- business-standard

The rebalancing act for 2018

- business-standard

Snippets: Uncertain times

- business-standard

From Kafa to coffee

- business-standard

Rampaging Rohit flattens Lanka

- deccanherald.com

Letters: Ban on condom ads

- business-standard

Letters: Flight of fancy

- business-standard

Letters: Another hasty move

- business-standard

Search says it all

- business-standard

New realities in Nepal

- business-standard

Tread cautiously

- business-standard

PHE employees project demands

- news.statetimes.in
Hashtags:   

Zydus

 | 

Cadila

 | 

gets

 | 

USFDA

 | 

nod

 | 

for

 | 

migraine

 | 

drug

 |